The global infectious disease molecular diagnostics market is experiencing a surge in demand, driven by the need for faster and more accurate diagnoses. In 2022, the market reached an estimated value of US$ 35 billion, and this momentum is expected to continue. A projected healthy Compound Annual Growth Rate (CAGR) of 4.2% will see the …